Kinder Morgan (KMI) stock dipped 1.86% to $27.93, lagging the S&P 500's 0.37% gain. The company's upcoming earnings release is expected to report an EPS of $0.29, a 16% rise from the same quarter last year, and a revenue of $4.17 billion, a 12.66% growth. The Zacks Rank is currently #3 (Hold), and the Forward P/E ratio is 22.53, a premium compared to the industry average. The PEG ratio is 3.35, higher than the industry average of 2.25.
Kinder Morgan (KMI) closed the most recent trading day at $27.93, marking a 1.86% decline from the previous session. This performance lagged the S&P 500's 0.37% gain, while the Dow dropped 0.14% and the Nasdaq rose 0.71%. Despite the dip, Kinder Morgan's stock has shown resilience, gaining 7.03% over the past month, outpacing the broader Oils-Energy sector's 2.31% gain and the S&P 500's 4.26% increase.
The upcoming earnings release for Kinder Morgan is highly anticipated. Analysts expect the company to report an earnings per share (EPS) of $0.29, representing a 16% increase from the same quarter last year. Revenue is forecast to reach $4.17 billion, a 12.66% growth compared to the corresponding quarter of the prior year. For the full fiscal year, Zacks Consensus Estimates project earnings of $1.26 per share and revenue of $16.97 billion, indicating year-over-year growth of 9.57% and 12.37%, respectively.
Kinder Morgan's valuation metrics reveal a premium compared to industry averages. The company's Forward P/E ratio stands at 22.53, higher than the industry average of 16.48. Similarly, the PEG ratio of 3.35 exceeds the industry average of 2.25, reflecting higher projected earnings growth.
The Zacks Rank for Kinder Morgan is currently #3 (Hold), indicating a neutral outlook based on analyst estimates and performance metrics. The company's extensive pipeline network and robust project backlog of $9 billion position it well for future growth, particularly in natural gas infrastructure and LNG exports.
Investors should monitor Kinder Morgan's upcoming earnings release and keep an eye on analyst estimates and valuation metrics for further insights into the company's financial health and stock performance.
Comments
No comments yet